James C. Cusack
Impact in
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Polyomavirus and related diseases
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 1%
- NF-κB Signaling Pathways
Papers in
- Oncology 41
- Colorectal Cancer Surgical Treatments 11
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 6
-
- Ubiquitin and proteasome pathways 9
- Co-authors
- Albert S. Baldwin (5 shared papers)Rong Liu (7 shared papers)Cun-Yu Wang (1 shared paper)Julian Adams (2 shared papers)Peter J. Elliott (2 shared papers)Jack A. Roth (4 shared papers)Laurie B. Owen‐Schaub (2 shared papers)Michael E. Houston (2 shared papers)
- Journals
- Annals of Surgical Oncology (8 papers)Journal of Clinical Oncology (5 papers)The American Journal of Surgery (4 papers)Clinical Cancer Research (4 papers)Surgical Oncology Clinics of North America (4 papers)
- Partner nations
- United StatesUgandaUnited Kingdom
In The Last Decade
James C. Cusack
86 papers receiving 5.2k citations
James C. Cusack's Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 2.4k
- Cancer Research 1.2k
- Molecular Biology 2.5k
- Toxicology 102
- Biotechnology 258
Countries citing papers authored by James C. Cusack
This map shows the geographic impact of James C. Cusack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Cusack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Cusack more than expected).
Fields of papers citing papers by James C. Cusack
This network shows the impact of papers produced by James C. Cusack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Cusack. The network helps show where James C. Cusack may publish in the future.
Co-authors
The 25 scholars most cited alongside James C. Cusack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB Hit paper breakdown → | 1999 | 917 |
| 2 | Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression Hit paper breakdown → | 1995 | 635 |
| 3 | Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. | 2001 | 473 |
| 4 | 1996 | 301 | |
| 5 | 2001 | 281 | |
| 6 | Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation. | 2000 | 149 |
| 7 | 2003 | 114 | |
| 8 | 2012 | 109 | |
| 9 | Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. | 1996 | 97 |
| 10 | 2012 | 89 | |
| 11 | 2000 | 89 | |
| 12 | 2003 | 87 | |
| 13 | 2013 | 87 | |
| 14 | 2012 | 84 | |
| 15 | Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. | 1999 | 84 |
| 16 | 2006 | 80 | |
| 17 | In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. | 1997 | 79 |
| 18 | 1999 | 77 | |
| 19 | 2019 | 77 | |
| 20 | 1994 | 75 |
About James C. Cusack
James C. Cusack is a scholar working on Oncology, Molecular Biology, Cancer Research, Surgery and Genetics, having authored 93 papers that have together received 5.4k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (11 papers), Ubiquitin and proteasome pathways (9 papers), NF-κB Signaling Pathways (9 papers), Virus-based gene therapy research (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Colorectal and Anal Carcinomas (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.2k citations), Molecular Biology (2.5k citations), Toxicology (102 citations) and Biotechnology (258 citations). James C. Cusack has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include Albert S. Baldwin, Rong Liu, Cun-Yu Wang, Julian Adams, Peter J. Elliott, Jack A. Roth, Laurie B. Owen‐Schaub, Michael E. Houston, Derek J. Erstad and Albert Deisseroth. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, The American Journal of Surgery, Clinical Cancer Research and Surgical Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.